The expression of the P2X7 receptor increases in bone cancer pain, and the injection of a P2X7 receptor antagonist in the ventrolateral region of the periaqueductal gray could partially antagonize the analgesic effect of tramadol on bone cancer pain in rats (Li et al., 2018). Here, P2RX7 is linked to bone cancer.